NIH-funded research R21 grant

Effects of prenatal exposure to chemicals on mother-infant interactions and development

Official title: Prenatal endocrine-disrupting chemicals, pandemic-related stress and social risk in mothers and infants

Funded at Columbia University Health Sciences · NIH-10573800 · Data updated 2026-11-12

This study is looking at how certain chemicals found in everyday products might affect the way pregnant women connect with their babies, especially during the challenges of the COVID-19 pandemic, and it’s for expectant moms who want to understand how these factors could influence their baby's development.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2026
Funding year2023
Award (this year)$259,200
NIH project number1R21ES034858-01
Project IDNIH-10573800 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pregnant women who are in their third trimester and may have been exposed to bisphenols.

Less likely to help

Patients who are not pregnant or those who are not in their third trimester may not receive any benefit from this research.

What this research studies

This research investigates how exposure to endocrine-disrupting chemicals, specifically bisphenols, during pregnancy affects the interactions between mothers and their infants. By recruiting pregnant women and analyzing urine samples for chemical exposure, the study aims to understand how these chemicals may disrupt maternal behaviors and influence infant social and cognitive development. The research also considers the added stress from the COVID-19 pandemic, which may further impact these interactions. The goal is to provide a detailed assessment of mother-infant interactions to identify potential risks associated with chemical exposure.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and interventions to enhance mother-infant bonding and developmental outcomes for infants.

How similar studies have gone: Previous research has shown that prenatal exposure to similar chemicals can negatively impact maternal behaviors and child development, indicating that this study builds on established findings.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Herbstman, Julie Beth — Columbia University Health Sciences
  • Study coordinator: Herbstman, Julie Beth

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.